Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease

Objectives Loss of intestinal barrier function plays an important role in the pathogenesis of inflammatory bowel disease (IBD). Shedding of intestinal epithelial cells is a potential cause of barrier loss during inflammation. The objectives of the study were (1) to determine whether cell shedding and barrier loss in humans can be detected by confocal endomicroscopy and (2) whether these parameters predict relapse of IBD. Methods Confocal endomicroscopy was performed in IBD and control patients using intravenous fluorescein to determine the relationship between cell shedding and local barrier dysfunction. A grading system based on appearances at confocal endomicroscopy in humans was devised and used to predict relapse in a prospective pilot study of 47 patients with ulcerative colitis and 11 patients with Crohn's disease. Results Confocal endomicroscopy in humans detected shedding epithelial cells and local barrier defects as plumes of fluorescein effluxing through the epithelium. Mouse experiments demonstrated inward flow through some leakage-associated shedding events, which was increased when luminal osmolarity was decreased. In IBD patients in clinical remission, increased cell shedding with fluorescein leakage was associated with subsequent relapse within 12 months after endomicroscopic examination (p<0.001). The sensitivity, specificity and accuracy for the grading system to predict a flare were 62.5% (95% CI 40.8% to 80.4%), 91.2% (95% CI 75.2 to 97.7) and 79% (95% CI 57.7 to 95.5), respectively. Conclusions Cell shedding and barrier loss detected by confocal endomicroscopy predicts relapse of IBD and has potential as a diagnostic tool for the management of the disease.

[1]  J. Schulzke,et al.  Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. , 2001, Gastroenterology.

[2]  U Wahnschaffe,et al.  Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease , 2006, Gut.

[3]  JORGE BEJARANO [Significance of WHO]. , 1953, Revista colombiana de pediatria y puericultura.

[4]  J. Söderholm,et al.  Importance of disrupted intestinal barrier in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[5]  Liping Su,et al.  Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. , 2009, Gastroenterology.

[6]  H. Buhr,et al.  Permanently increased mucosal permeability in patients with backwash ileitis after ileoanal pouch for ulcerative colitis , 2008, Scandinavian journal of gastroenterology.

[7]  C. Loddenkemper,et al.  Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients , 2008, Gut.

[8]  C. Weber,et al.  Tight junction pore and leak pathways: a dynamic duo. , 2011, Annual review of physiology.

[9]  A. Watson,et al.  Redistribution of the tight junction protein ZO-1 during physiological shedding of mouse intestinal epithelial cells. , 2011, American journal of physiology. Cell physiology.

[10]  J. Meddings The significance of the gut barrier in disease , 2007, Gut.

[11]  H. Lochs,et al.  Intestinal permeability and the prediction of relapse in Crohri's disease , 1993, The Lancet.

[12]  K. Madsen,et al.  Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse , 2008, Gut.

[13]  J. Wallace,et al.  Sucrose: a novel permeability marker for gastroduodenal disease. , 1993, Gastroenterology.

[14]  J. Madara,et al.  Villus contraction aids repair of intestinal epithelium after injury. , 1989, The American journal of physiology.

[15]  P. Rutgeerts,et al.  Increased permeability of macroscopically normal small bowel in Crohn's disease , 1994, Digestive Diseases and Sciences.

[16]  J. S. Lee,et al.  Epithelial cell extrusion during fluid transport in canine small intestine. , 1977, The American journal of physiology.

[17]  G. Verbeke,et al.  Clustering of increased small intestinal permeability in families with Crohn's disease. , 1997, Gastroenterology.

[18]  Yanfang Guan,et al.  Mechanisms of Epithelial Cell Shedding in the Mammalian Intestine and Maintenance of Barrier Function , 2009, Annals of the New York Academy of Sciences.

[19]  S. Savkovic,et al.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation , 2003, Gut.

[20]  R. Hilsden,et al.  Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. , 1996, Gastroenterology.

[21]  A. Marchiando,et al.  Epithelial barriers in homeostasis and disease. , 2010, Annual review of pathology.

[22]  Fiona Campbell,et al.  Characterization of epithelial cell shedding from human small intestine , 2006, Laboratory Investigation.

[23]  J. S. Lee Contraction of villi and fluid transport in dog jejunal mucosa in vitro. , 1971, The American journal of physiology.

[24]  M. Fromm,et al.  Adaptation of the jejunal mucosa in the experimental blind loop syndrome: changes in paracellular conductance and tight junction structure. , 1987, Gut.

[25]  D. Duerksen,et al.  Intestinal Permeability in Long-Term Follow-up of Patients with Celiac Disease on a Gluten-Free Diet , 2005, Digestive Diseases and Sciences.

[26]  Stefan Schreiber,et al.  Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[27]  Marshall H. Montrose,et al.  Caveolin-1–dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo , 2010, The Journal of cell biology.

[28]  A. Kaser,et al.  Crohn's disease: NOD2, autophagy and ER stress converge , 2011, Gut.

[29]  M. Arrieta,et al.  Alterations in intestinal permeability , 2006, Gut.

[30]  B. Claggett,et al.  Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters. , 2011, Gastrointestinal endoscopy.

[31]  M. Fromm,et al.  Measurement of paracellular epithelial conductivity by conductance scanning , 1997, Pflügers Archiv.

[32]  S. Zeissig,et al.  High‐Resolution Analysis of Barrier Function , 2009, Annals of the New York Academy of Sciences.

[33]  Markus F Neurath,et al.  Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. , 2007, Gastroenterology.

[34]  G. May,et al.  Is small intestinal permeability really increased in relatives of patients with Crohn's disease? , 1993, Gastroenterology.

[35]  P. Munkholm,et al.  Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. , 1994, Gut.

[36]  J. Schulzke,et al.  Restitution of single-cell defects in the mouse colon epithelium differs from that of cultured cells. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[37]  T. Matsui,et al.  VALIDITY OF ACTIVITY INDICES IN ULCERATIVE COLITIS: COMPARISON OF CLINICAL AND ENDOSCOPIC INDICES , 2010, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[38]  A. Watson,et al.  Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. , 2005, Gastroenterology.

[39]  A. Watson,et al.  The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. , 2011, Gastroenterology.